• Drove 45% topline growth and 46% in net profit in FY2022, won Halma Global “Company of the Year” award• Re-structured the leadership team inline with corporate development, recruiting a national sales lead, a corporate strategy lead, an operation VP and acting as export business lead myself• RE-structured Commercial team including Sales, Marketing, Technique Service, and maintenance service to better meet customer’s needs• Led leadership team to drive operation continuing improvement cross over all functional teams • Strengthened public and government relationships, won “Little Giant” award in August 2023 issued by China Ministry of Industry and Information Technology

• Led CERENOVUS business across APAC region including China, Japan, Korea, ANZ, India and South East Asia countries • Drove CERENOVUS APAC business growth at 35% CAGR since 2018 and reached to $180MM in 2021, bringing APAC region not only the biggest contributor among all WW regions but also the biggest contributor to WW growth• Drove China business to 45% CAGR since 2018, making China as the biggest single country contributor in CERENOVUS global• Supported RA teams in accelerating multiple NPI launches across APAC countries• Launched CERENOVUS the company brand as divisional new branding across APAC region• Built up APAC advisory board strengthening KOLs engagement• Liaised global R&D with top KOLs in Asia in product development, facilitated localization project• Activated APAC team of 270 members the winning spirit, built up customer centricity culture among APAC teams• Enhanced talent capability through cross-country talent exchange project

• Led a team of 30 marketing professionals in developing and executing marketing strategies and programs• Achieved 10% growth in a market with 75 competitors• Developed products pricing strategy for VBP – volume based procurement• Liaised global source in accelerating NPIs in China• Re-structured marketing team • Supported local R&D team in developing products for customer un-met needs

• Led the NEURO marketing team in achieving 35%-50% growth through NPI acceleration • Built up China neuro KOLs database and platform • Coordinated with local business partners in serving tailor made products• Developed a library of clinical papers, technical data, promotion materials • Built up connection with Japan and Korea teams for cross boarder activities

• Drove neuro business 30% CAGR from 2009-2015 • Facilitated local value product developed in Japan through collaboration with local KOLs and global R&D team• Built up APAC advisory board including top KOLs and young rising stars

Achievements: • Built the leading product brand (Behring Albumin) awareness in China through marketing strategies and programs• Managed the product (Albumin) from ranked No. 6 of 8% market share up to the country No.1 of 30% market share in 3 years.• Successful pre-launched new category product (flu vaccine) through market survey and pre-launch activities

Achievements: • Successful launched new generation bioabsorbable coil (Matrix) for aneurysm treatment, gained 25% market share in the first launch year.• Successful launch world first intracranial stent (Neuroform) through key cities new technique physician training which covered over 200 doctors• Built up China key opinion leaders and BSC training centers

Achievements: • Rewared as national top sales for 2 years.• Developed and maintained the responsible product – DNA recombinant growth hormone – Genotropin being the market leader in China for 4 years• Built up Genetropin Growth Centers in key cities functioning as physician training center / patient education center / Genotropin Scientific Events Center

Resident doctor, specialist of Infectious Disease